方盛制药(603998.SH)：妇科止血消痛颗粒药物临床试验获批准

Group 1 - The core point of the article is that Fangsheng Pharmaceutical's subsidiary, GuangDong Fangsheng R&D Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for its innovative traditional Chinese medicine project, specifically the gynecological hemostatic and analgesic granules [1] - The approval allows the company to conduct Phase II and III clinical trials after further refining the clinical trial protocol [1]